Ailin for healthcare professionals
Early detection at scale
Design, deploy and manage screening programmes in a scalable way. Frictionless.
Pharmaceutical laboratories
From awareness to real clinical evidence on a single platform
Public health
Early detection at scale with care sustainability
Insurers
Prevention that improves retention and optimises the cost of care
Private health
Expand your health offer with an already integrated infrastructure
Companies
Measurable wellbeing for your team, with minimal operational burden
With the confidence of health leaders
Infrastructure for early diagnosis
From detection to evidence and treatment, in a connected ecosystem
Ailin connects the entire screening pathway: from screening and out-of-clinic testing to AI reporting and real-time data recording, to detect risk early and generate robust evidence for personalised patient follow-up.
Evidence accessible from anywhere
Our certified kits (CE-IVD) allow for simple and safe sampling in both clinical and non-clinical settings, reducing the burden on care without compromising the reliability of the process.
Scientific rigour
Samples are analysed in accredited laboratories integrated in our platform, maintaining high standards of quality and safety and allowing the incorporation of new centres under these same criteria.
Accompanying the user every step of the way
The platform guides the user from kit activation to receipt of results, ensuring a clear, structured and easy to understand experience.
Simple clinical management at scale
The platform provides healthcare professionals with a structured and prioritised view of participants and their outcomes, facilitating clinical review, personalised reporting and communication without losing clinical control.
AI trained by and for doctors
The platform integrates an AI developed with healthcare professionals that combines laboratory results and clinical information to generate structured reports ready for medical review and validation.
Generating evidence in population health
Aggregated and anonymised results allow for population-based analyses that contribute to prevention, research and informed decision-making.
Infrastructure for early diagnosis
From detection to evidence and treatment, in a connected ecosystem
Ailin connects the entire screening pathway: from screening and out-of-clinic testing to AI reporting and real-time data recording, to detect risk early and generate robust evidence for personalised patient follow-up.
Results that speak for themselves
Organisations from all sectors already rely on our diagnostic infrastructure
